Authors: Edmonson, JH Suman, VJ Dalton, RJ Bro, WC Gallenberg, MM Long, HJ Levitt, R Hatfield, AK Krook, JE Mailliard, JA Gerstner, JB

Citation: Jh. Edmonson et al., Comparison of conventional dose and double dose carboplatin in patients receiving cyclophosphamide plus carboplatin for advanced ovarian carcinoma: Anorth central cancer treatment group study, CANCER INV, 19(6), 2001, pp. 597-602

Authors: Bonner, JA Sloan, JA Shanahan, TG Brooks, BJ Marks, RS Krook, JE Gerstner, JB Maksymiuk, A Levitt, R Mailliard, JA Tazelaar, HD Hillman, S Jett, JR

Citation: Ja. Bonner et al., Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma, J CL ONCOL, 17(9), 1999, pp. 2681-2691

Authors: Burch, PA Keppen, MD Schroeder, G Rubin, J Krook, JE Dalton, RJ Gerstner, JB Jancewicz, MT Ebbert, LP

Citation: Pa. Burch et al., North Central Cancer Treatment Group phase II study of 5-fluorouracil and high-dose levamisole for gastric and gastroesophageal cancer using survivalas the primary endpoint of efficacy, AM J CL ONC, 22(5), 1999, pp. 505-508

Authors: Kirschling, RJ Grill, JP Marks, RS Kugler, JW Gerstner, JB Kuross, SA Michalak, JC Windschitl, HE Krewer, KD Jett, JR

Citation: Rj. Kirschling et al., Paclitaxel and G-CSF in previously untreated patients with extensive stagesmall-cell lung cancer - A phase II study of the North Central Cancer Treatment Group, AM J CL ONC, 22(5), 1999, pp. 517-522

Authors: Marschke, RF Grill, JP Sloan, JA Wender, DB Levitt, R Mailliard, JA Gerstner, JB Ghosh, C Morton, RF Jett, JR

Citation: Rf. Marschke et al., Phase II study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer, AM J CL ONC, 22(1), 1999, pp. 15-17